Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells

Keyphrases

• Acute Monocytic Leukemia 100%
• All-trans Retinoic Acid 18%
• Ca(II) 9%
• Cell Culture Supernatant 9%
• Cell Cycle Arrest 9%
• Cell Surface 9%
• Dendritic Cell Maturation 9%
• Differentiating Agents 9%
• Differentiation Therapy 9%
• Exosome Release 9%
• G(0) 9%
• Histamine 9%
• Human Plasma 100%
• Induced Differentiation 100%
• Inflammatory Mediators 9%
• Intercellular Communication 9%
• Leaderless mRNA 9%
• Leukemia Cells 9%
• Macrophage Differentiation 9%
• Monocyte-to-macrophage Differentiation 9%
• Monocytes 9%
• Monocytic Leukemia Cells 100%
• Myeloid Cell Differentiation 9%
• Peripheral Blood Monocytes 18%
• Plasma Membrane Vesicles 100%
• Promonocytes 18%
• Receptor Antagonist 9%
• SB431542 9%
• Terminal Differentiation 18%
• TGF-1 54%
• TGF-β Receptor 9%
• THP-1 Cells 27%
• THP1 100%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Monocytic Leukemia 100%
• Cell Culture 50%
• Histamine 50%
• Leukemia 50%
• Receptor Antagonist 50%
• Retinoic Acid 100%

Immunology and Microbiology

• Cell Communication 9%
• Cell Culture 9%
• Cell Cycle Arrest 9%
• Cell Cycle Checkpoint 9%
• Cell Differentiation 9%
• Cell Maturation 9%
• Cell Membrane 100%
• Cell Surface 9%
• Dendritic Cell 9%
• Exosome 9%
• Histamine 9%
• Leukemia Cell 100%
• Macrophage Differentiation 18%
• Mediator 9%
• Myeloid 18%
• Promonocyte 18%